Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
With labs located in both Europe and the U.S., BioAgilytix provides global bioanalytical services for biomarkers, immunogenicity, PK, and cell-based assays supporting the development and release testing of biologics across multiple industries and disease states. Additionally, BioAgilytix boasts extensive experience analyzing gene therapy solutions across viral vectors, leveraging NAb assays to test for neutralizing activity against the vector of gene therapy. In our NEW Gene & Cell Therapy Web Center, our scientists share their expert perspectives on evolving methods and trends in cell & gene therapy bioanalysis. Speak with our experts today!
Language:
English
Who can attend? Everyone
Featured Presenters
Chief Scientific Officer, North America
Dr. McNally is a recognized thought leader in the development and application of bioanalytical methods used in regulatory submissions and is specifically skilled in progression of biotherapeutics from research through clinical development. He has a special interest in the immunogenicity of biotherapeutics and leads an industry-wide working group to address this issue. A key part of his role at BioAgilytix is advising on emerging scientific developments and providing scientific and regulatory guidance.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents